Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Other Non-Current Assets came in at $11.3 million in Q1 2026, down 26.97% year-on-year from $15.5 million in Q1 2025, and down 24.54% quarter-over-quarter from $15.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.3 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 26.97% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 26.97% decrease from a year earlier, with the FY2025 full-year figure at $15.0 million, down 8.74% from the prior year.
- Other Non-Current Assets fell to $11.3 million in Q1 2026 per AAWH's latest filing, from $15.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $25.7 million in Q1 2024 and bottomed at $11.3 million in Q1 2026.
- The 5-year median for Other Non-Current Assets is $19.3 million (2022), against an average of $18.4 million.
- Across the five-year window, Other Non-Current Assets jumped 31.1% in 2024 and sank 39.76% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $19.3 million in 2022, then increased by 19.59% to $23.1 million in 2023, then slipped by 28.77% to $16.4 million in 2024, then declined by 8.74% to $15.0 million in 2025, then fell by 24.54% to $11.3 million in 2026.
- Per Business Quant, the three latest AAWH Other Non-Current Assets figures stand at $11.3 million (Q1 2026), $15.0 million (Q4 2025), and $15.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.34 Mn |
| Jun 30, 2025 | 15.37 Mn |
| Mar 31, 2025 | 15.49 Mn |
| Dec 31, 2024 | 16.43 Mn |
| Sep 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 19.89 Mn |
| Mar 31, 2024 | 25.71 Mn |
| Dec 31, 2023 | 23.06 Mn |
| Sep 30, 2023 | 19.77 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Mar 31, 2023 | 19.61 Mn |
| Dec 31, 2022 | 19.28 Mn |
| Sep 30, 2022 | 18.84 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 19.93 Mn |
| Dec 31, 2021 | 19.57 Mn |
| Sep 30, 2021 | 19.76 Mn |
| Jun 30, 2021 | 21.84 Mn |